LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 97 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 42 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $1,000 | – | 42 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 42 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | 0.0% | 42 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | – | 42 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 42 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |